Review
Published on 04 Nov 2024
Research progress of the SLFN family in malignant tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1468484
- 2,693 views
- 5 citations
Type at least 3 characters
3,144 articles
articles
Review
Published on 31 Oct 2024
The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1424218
- 5,259 views
- 9 citations
Original Research
Published on 31 Oct 2024
Development and validation of a tumor marker-based model for the prediction of lung cancer: an analysis of a multicenter retrospective study in Shanghai, China
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1427170
- 2,708 views
- 1 citation
Original Research
Published on 30 Oct 2024
The capture of circulating tumor cells by Labyrinth system as a tool for early stage lung cancer detection
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1474015
- 1,970 views
Systematic Review
Published on 28 Oct 2024
A bibliometric and visualization analysis of entosis research from 2007 to 2024
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1424100
- 2,993 views
- 2 citations
Original Research
Published on 25 Oct 2024
Identification of lncRNA dual targeting PD-L1 and PD-L2 as a novel prognostic predictor for gastric cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1341056
- 5,458 views
- 11 citations
Original Research
Published on 23 Oct 2024
CRISPR-based molecule-regulatory expression platform for specific immunotherapy of cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1469319
- 1,828 views
- 1 citation
Review
Published on 22 Oct 2024
The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1445978
- 3,486 views
- 3 citations
Original Research
Published on 21 Oct 2024
METTL3 affects the biological function of lung adenocarcinoma through the FGF2/PI3K/AKT /mTOR pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1474701
- 1,873 views
- 2 citations
Original Research
Published on 21 Oct 2024
Serum extracellular vesicles 3’tRF-ThrCGTand 3’tRF-mtlleGAT combined with tumor markers can serve as minimally invasive diagnostic predictors for colorectal cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1474095
- 2,049 views
- 2 citations
Original Research
Published on 21 Oct 2024
Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1435537
- 5,457 views
- 6 citations
Editorial
Published on 18 Oct 2024
Editorial: Revolutionizing cancer care: the promise of liquid biopsy assays for healthcare equity
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1493833
- 1,527 views
Original Research
Published on 17 Oct 2024
Characterization of ligand-receptor pair in acute myeloid leukemia: a scoring model for prognosis, therapeutic response, and T cell dysfunction
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1473048
- 2,322 views
Original Research
Published on 10 Oct 2024
Expression of HOTAIR and PTGS2 as potential biomarkers in chronic myeloid leukemia patients in Brazil
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1443346
- 2,033 views
Review
Published on 08 Oct 2024
Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1441460
- 8,177 views
- 11 citations
Original Research
Published on 01 Oct 2024
Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1460150
- 4,284 views
- 7 citations
Case Report
Published on 01 Oct 2024
Case report: Germline CHEK2 mutation is associated with a giant cell glioblastoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1361928
- 2,618 views
- 1 citation
Editorial
Published on 27 Sep 2024
Editorial: Molecular mechanisms and immunotherapeutic targets in nanomedicine-based cancer therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1468397
- 1,001 views
Original Research
Published on 24 Sep 2024
Extracellular vesicles from cancer cell lines of different origins drive the phenotype of normal oral fibroblasts in a CAF-like direction
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1456346
- 3,020 views
- 5 citations
Original Research
Published on 24 Sep 2024
Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1453164
- 1,938 views
- 2 citations
Review
Published on 19 Sep 2024
Deciphering the role of claudins in lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1435535
- 2,789 views
- 3 citations
Review
Published on 16 Sep 2024
The role and mechanism of compressive stress in tumor
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1459313
- 3,971 views
- 7 citations
Brief Research Report
Published on 13 Sep 2024
Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1466255
- 3,953 views
- 4 citations
Original Research
Published on 13 Sep 2024
Alveolar type 2 cells marker gene SFTPC inhibits epithelial-to-mesenchymal transition by upregulating SOX7 and suppressing WNT/β-catenin pathway in non-small cell lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1448379
- 4,911 views
- 5 citations